相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The need for histological subclassification of cirrhosis: a systematic review and meta-analysis
Gaeun Kim et al.
LIVER INTERNATIONAL (2016)
Assessment for Risk of Bias in Systematic Reviews and Meta-Analyses in the Field of Hepatology
Gaeun Kim et al.
GUT AND LIVER (2015)
Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis
Gaeun Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review
Gaeun Kim et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Mesenchymal stem cell therapy for liver fibrosis
Young Woo Eom et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2015)
Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
Won Ki Hong et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Invasive and non-invasive diagnosis of cirrhosis and portal hypertension
Moon Young Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
Jae Hyun Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2014)
Overview and recent trends of systematic reviews and meta-analyses in hepatology
Gaeun Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2014)
Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation
O. Guillaud et al.
TRANSPLANTATION PROCEEDINGS (2013)
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study
Moon Young Kim et al.
LIVER INTERNATIONAL (2012)
The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort
Barham K. Abu Dayyeh et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
The role of the renin-angiotensin system in liver fibrosis
M. Kamruzzman Munshi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Reduction of Advanced Liver Fibrosis by Short-Term Targeted Delivery of an Angiotensin Receptor Blocker to Hepatic Stellate Cells in Rats
Montserrat Moreno et al.
HEPATOLOGY (2010)
Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis
Puneeta Tandon et al.
JOURNAL OF HEPATOLOGY (2010)
The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C
Kathleen E. Corey et al.
LIVER INTERNATIONAL (2009)
Renin-angiotensin system in the pathogenesis of liver fibrosis
Regina Maria Pereira et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model
Moon Young Kim et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Impact of inhibitors of the renin-angiotensin-aldosterone system on liver fibrosis and portal hypertension
U. Tox et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study
Silvia Sookoian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function
CM Ferrario et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Antifibrotic therapy in chronic liver disease
DC Rockey
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation
A Rimola et al.
TRANSPLANTATION (2004)
Inflammation and angiotensin II
Y Suzuki et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C
Y Terui et al.
HEPATOLOGY (2002)
分享论文
